HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 190 filers reported holding HERON THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.41 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,012,499 | +17.4% | 983,009 | +32.2% | 0.00% | – |
Q2 2023 | $862,552 | -21.9% | 743,579 | +1.7% | 0.00% | – |
Q1 2023 | $1,104,000 | -44.7% | 731,126 | -8.4% | 0.00% | -100.0% |
Q4 2022 | $1,995,113 | -36.2% | 798,045 | +7.7% | 0.00% | 0.0% |
Q3 2022 | $3,128,000 | +53.3% | 741,006 | +1.4% | 0.00% | 0.0% |
Q2 2022 | $2,040,000 | -50.1% | 731,055 | +2.2% | 0.00% | 0.0% |
Q1 2022 | $4,092,000 | -35.6% | 715,306 | +2.7% | 0.00% | -50.0% |
Q4 2021 | $6,357,000 | -14.6% | 696,257 | -0.0% | 0.00% | 0.0% |
Q3 2021 | $7,446,000 | -24.7% | 696,526 | +9.3% | 0.00% | -33.3% |
Q2 2021 | $9,894,000 | +7.1% | 637,446 | +11.9% | 0.00% | 0.0% |
Q1 2021 | $9,234,000 | -21.2% | 569,611 | +2.9% | 0.00% | -40.0% |
Q4 2020 | $11,720,000 | +45.6% | 553,741 | +2.0% | 0.01% | +25.0% |
Q3 2020 | $8,049,000 | +1.4% | 543,084 | +0.6% | 0.00% | 0.0% |
Q2 2020 | $7,941,000 | +35.7% | 539,836 | +8.3% | 0.00% | +33.3% |
Q1 2020 | $5,852,000 | -49.4% | 498,460 | +1.4% | 0.00% | -50.0% |
Q4 2019 | $11,557,000 | +46.4% | 491,775 | +15.3% | 0.01% | +20.0% |
Q3 2019 | $7,893,000 | +1.6% | 426,613 | +2.1% | 0.01% | 0.0% |
Q2 2019 | $7,766,000 | -19.8% | 417,738 | +5.4% | 0.01% | -16.7% |
Q1 2019 | $9,684,000 | -2.2% | 396,219 | +3.9% | 0.01% | -25.0% |
Q4 2018 | $9,897,000 | -17.5% | 381,505 | +0.6% | 0.01% | 0.0% |
Q3 2018 | $11,997,000 | -6.1% | 379,045 | +15.2% | 0.01% | -11.1% |
Q2 2018 | $12,781,000 | +71.5% | 328,981 | +21.8% | 0.01% | +50.0% |
Q1 2018 | $7,453,000 | +69.5% | 270,016 | +11.1% | 0.01% | +100.0% |
Q4 2017 | $4,398,000 | +68.9% | 242,934 | +50.7% | 0.00% | +50.0% |
Q3 2017 | $2,604,000 | +10.2% | 161,199 | -5.5% | 0.00% | 0.0% |
Q2 2017 | $2,363,000 | -7.1% | 170,555 | +0.6% | 0.00% | -33.3% |
Q1 2017 | $2,543,000 | +61.3% | 169,529 | +40.9% | 0.00% | +50.0% |
Q4 2016 | $1,577,000 | -27.5% | 120,318 | -4.7% | 0.00% | -33.3% |
Q3 2016 | $2,176,000 | +7.8% | 126,268 | +13.0% | 0.00% | 0.0% |
Q2 2016 | $2,018,000 | +3.2% | 111,768 | +8.5% | 0.00% | 0.0% |
Q1 2016 | $1,956,000 | -27.4% | 102,996 | +2.1% | 0.00% | -25.0% |
Q4 2015 | $2,694,000 | +25.2% | 100,892 | +14.5% | 0.00% | +33.3% |
Q3 2015 | $2,151,000 | +54.9% | 88,116 | +97.7% | 0.00% | +50.0% |
Q2 2015 | $1,389,000 | +133.1% | 44,560 | +8.8% | 0.00% | +100.0% |
Q1 2015 | $596,000 | +45.4% | 40,950 | +0.5% | 0.00% | 0.0% |
Q4 2014 | $410,000 | +20.6% | 40,750 | 0.0% | 0.00% | 0.0% |
Q3 2014 | $340,000 | -3.4% | 40,750 | +43.0% | 0.00% | 0.0% |
Q2 2014 | $352,000 | – | 28,500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANG KEVIN C | 760 | $783 | 100.00% |
Velan Capital Investment Management LP | 6,986,744 | $7,196,346 | 5.80% |
Tejara Capital Ltd | 2,109,681 | $2,172,971 | 1.23% |
JW Asset Management, LLC | 2,407,418 | $2,479,641 | 1.07% |
Rubric Capital Management LP | 26,713,503 | $27,514,908 | 1.03% |
GREAT POINT PARTNERS LLC | 4,737,368 | $4,879,489 | 0.89% |
Orchard Capital Management, LLC | 2,142,823 | $2,207,108 | 0.82% |
Clearline Capital LP | 6,149,842 | $6,334,338 | 0.54% |
CM Management, LLC | 450,000 | $463,500 | 0.49% |
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 327,450 | $337,274 | 0.48% |